Cargando…

PRL-3 is a potential glioblastoma prognostic marker and promotes glioblastoma progression by enhancing MMP7 through the ERK and JNK pathways

Purpose: Glioblastoma is the most common and aggressive type of primary brain malignancy and is associated with a poor prognosis. Previously, we found that phosphatase of regenerating liver-3 (PRL-3) was significantly up-regulated in glioblastoma as determined by a microarray analysis. However, the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mu, Nan, Gu, Jintao, Liu, Nannan, Xue, Xiaochang, Shu, Zhen, Zhang, Kuo, Huang, Tonglie, Chu, Chu, Zhang, Wangqian, Gong, Li, Zhao, Huadong, Jia, Bo, Gao, Dakuan, Shang, Lei, Zhang, Wei, Guo, Qingdong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5858165/ https://www.ncbi.nlm.nih.gov/pubmed/29556339 http://dx.doi.org/10.7150/thno.22699

Ejemplares similares

Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro
por: Huang, Tonglie, et al.
Publicado: (2015)

Engineered Extracellular Vesicle-Delivered CRISPR/Cas9 for Radiotherapy Sensitization of Glioblastoma
por: Liu, Xiao, et al.
Publicado: (2023)

Glioblastoma cells vampirize WNT from neurons and trigger a JNK/MMP signaling loop that enhances glioblastoma progression and neurodegeneration
por: Portela, Marta, et al.
Publicado: (2019)

Exosome-transmitted circCABIN1 promotes temozolomide resistance in glioblastoma via sustaining ErbB downstream signaling
por: Liu, Xiao, et al.
Publicado: (2023)

PRL1 Promotes Glioblastoma Invasion and Tumorigenesis via Activating USP36-Mediated Snail2 Deubiquitination
por: Qiu, Wenjin, et al.
Publicado: (2022)

Primary resistance to EGFR inhibition in glioblastoma is mediated by a TNF-JNK-Axl-ERK signaling axis
por: Guo, Gao, et al.
Publicado: (2017)

Kill two birds with one stone: Engineered exosome-mediated delivery of cholesterol modified YY1-siRNA enhances chemoradiotherapy sensitivity of glioblastoma
por: Liu, Xiao, et al.
Publicado: (2022)

A novel NF-κB/YY1/microRNA-10a regulatory circuit in fibroblast-like synoviocytes regulates inflammation in rheumatoid arthritis
por: Mu, Nan, et al.
Publicado: (2016)

PRL-3 promotes the motility, invasion, and metastasis of LoVo colon cancer cells through PRL-3-integrin β1-ERK1/2 and-MMP2 signaling
por: Peng, Lirong, et al.
Publicado: (2009)

RhoJ facilitates angiogenesis in glioblastoma via JNK/VEGFR2 mediated activation of PAK and ERK signaling pathways
por: Wang, Mei, et al.
Publicado: (2022)

GBP5 drives malignancy of glioblastoma via the Src/ERK1/2/MMP3 pathway
por: Yu, Xiaoting, et al.
Publicado: (2021)

MMP14 Contributes to HDAC Inhibition-Induced Radiosensitization of Glioblastoma
por: Zhou, Yuchuan, et al.
Publicado: (2021)

Targeting JNK for therapeutic depletion of stem-like glioblastoma cells
por: Matsuda, Ken-ichiro, et al.
Publicado: (2012)

Abscisic Acid-Induced Autophagy Selectively via MAPK/JNK Signalling Pathway in Glioblastoma
por: Zhou, Nan, et al.
Publicado: (2020)

Expression of Ferritin Light Chain (FTL) Is Elevated in Glioblastoma, and FTL Silencing Inhibits Glioblastoma Cell Proliferation via the GADD45/JNK Pathway
por: Wu, Tingfeng, et al.
Publicado: (2016)

Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer
por: Radke, I, et al.
Publicado: (2006)

Trop2 enhances invasion of thyroid cancer by inducing MMP2 through ERK and JNK pathways
por: Guan, Hongyu, et al.
Publicado: (2017)

miR-129-5p targets Wnt5a to block PKC/ERK/NF-κB and JNK pathways in glioblastoma
por: Zeng, Ailiang, et al.
Publicado: (2018)

PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
por: Thura, Min, et al.
Publicado: (2019)

MiR-130a-3p Inhibits PRL Expression and Is Associated With Heat Stress-Induced PRL Reduction
por: Zhang, Haojie, et al.
Publicado: (2020)

Inhibitor of Nicotinamide Phosphoribosyltransferase Sensitizes Glioblastoma Cells to Temozolomide via Activating ROS/JNK Signaling Pathway
por: Feng, Jun, et al.
Publicado: (2016)

Design and Computational Analysis of an MMP9 Inhibitor in Hypoxia-Induced Glioblastoma Multiforme
por: Kumari, Smita, et al.
Publicado: (2023)

Piperlongumine Inhibits Migration of Glioblastoma Cells via Activation of ROS-Dependent p38 and JNK Signaling Pathways
por: Liu, Qian Rong, et al.
Publicado: (2014)

Analysis and validation of aging-related genes in prognosis and immune function of glioblastoma
por: Mu, Jianhua, et al.
Publicado: (2023)

EIF4A3-induced circular RNA MMP9 (circMMP9) acts as a sponge of miR-124 and promotes glioblastoma multiforme cell tumorigenesis
por: Wang, Renjie, et al.
Publicado: (2018)

Author Correction: PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
por: Thura, Min, et al.
Publicado: (2021)

Correction to: EIF4A3-induced circular RNA MMP9 (circMMP9) acts as a sponge of miR-124 and promotes glioblastoma multiforme cell tumorigenesis
por: Wang, Renjie, et al.
Publicado: (2020)

Activation of JNK and p38 MAPK Mediated by ZDHHC17 Drives Glioblastoma Multiforme Development and Malignant Progression
por: Chen, Xueran, et al.
Publicado: (2020)

IFN-γ induces PD-L1 through p38/JNK/ERK signaling pathways and counteracts the tumor promoting effect mediated by PD-L1 in Glioblastoma
por: Jia, Huafang, et al.
Publicado: (2022)

Overexpression of Lipocalin-2 Inhibits Proliferation and Invasiveness of Human Glioblastoma Multiforme Cells by Activating ERK Targeting Cathepsin D Expression
por: Hsieh, Yi-Hsien, et al.
Publicado: (2021)

Chronic stress accelerates glioblastoma progression via DRD2/ERK/β-catenin axis and Dopamine/ERK/TH positive feedback loop
por: Wang, Yan, et al.
Publicado: (2023)

Therapeutic potential of PRL-3 targeting and clinical significance of PRL-3 genomic amplification in gastric cancer
por: Ooki, Akira, et al.
Publicado: (2011)

The critical role of ERK in death resistance and invasiveness of hypoxia-selected glioblastoma cells
por: Kim, Jee-Youn, et al.
Publicado: (2009)

Berberine inhibits angiogenesis in glioblastoma xenografts by targeting the VEGFR2/ERK pathway
por: Jin, Fa, et al.
Publicado: (2019)

ERK1/2 signaling regulates the immune microenvironment and macrophage recruitment in glioblastoma
por: Lailler, Claire, et al.
Publicado: (2019)

EGFR/SRC/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma
por: Fang, Runping, et al.
Publicado: (2021)

SIRT2 Promotes the Migration and Invasion of Gastric Cancer through RAS/ERK/JNK/MMP-9 Pathway by Increasing PEPCK1-Related Metabolism()()
por: Li, Yang, et al.
Publicado: (2018)

The ERK and JNK pathways in the regulation of metabolic reprogramming
por: Papa, Salvatore, et al.
Publicado: (2018)

FOXP3 Inhibits the Metastasis of Breast Cancer by Downregulating the Expression of MTA1
por: Liu, Chenlin, et al.
Publicado: (2021)

Analysis of molecular determinants of PRL-3
por: Pascaru, Mihaela, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_2t0905g72mjr4ptldoq9cu2i5u